Non-Valvular Atrial Fibrillation Management: How Superior Efficacy...

Ajouter une nouvelle offre d'emploi Health

2025-12-02 12:58:00 -

Non-Valvular Atrial Fibrillation Management: How Superior Efficacy and Bleeding Risk Data Are Cementing Apixaban Market Dominance

The Apixaban Market is experiencing remarkable market growth, driven largely by its superior convenience and positive impact on patient adherence compared to legacy anticoagulants. Older therapies, such as Vitamin K antagonists, require frequent blood monitoring, dietary restrictions, and complex dose adjustments, often leading to poor patient compliance and inconsistent therapeutic effects,...

0 Commentaires 0 Parts 331 Vue 0 Aperçu